Colgate-Palmolive Company

(New York Stock Exchange)
Somewhat Bullish +35

Colgate-Palmolive's 130-year dividend streak fa... | Pluang

πŸ“ˆ Colgate-Palmolive has extended its annual dividend increase streak to 63 years while maintaining continuous payments since 1895.

πŸ“‰ The company's North American business is currently shrinking, presenting a primary challenge to future organic growth targets.

πŸ’° The stock trades at a premium forward P/E of 21 with a market capitalization of $68.60 billion as of late September 2026.

πŸ“Š Investors are watching for stabilization in North American operations to justify the current high valuation multiple.

🎯 Management has issued mid-single-digit EPS growth guidance, which faces scrutiny given the regional headwinds.

πŸ’΅ The stock offers a dividend yield of 2.46%, providing income support despite growth concerns.

Bullish Signals
  • Colgate-Palmolive has paid dividends continuously since 1895 and recently extended its annual dividend increase streak to 63 years.
  • The company maintains strong dividend coverage, indicating a robust ability to service shareholder payouts despite market conditions.
Risk Factors
  • The North American business is shrinking, creating significant growth challenges that could impact future revenue expansion.
  • The stock trades at a premium forward P/E of 21, leaving little room for error if organic growth fails to materialize.
  • Current valuation levels suggest high expectations that may not be met given the lack of stabilization in key domestic markets.
Full Analysis
Colgate-Palmolive has maintained a continuous dividend payment streak since 1895, recently extending its annual increase run to 63 years. The company retains strong dividend coverage and holds a global leadership position within the consumer goods sector. Despite these defensive strengths, the firm faces significant headwinds as its North American business continues to shrink, creating distinct growth challenges for the long-term trajectory. This regional decline contrasts with the safety provided by its current high dividend yield of 2.46% and a market capitalization of $68.60 billion. The stock currently trades at a premium valuation with a forward P/E ratio of 21, reflecting high market expectations that may not be fully supported by organic growth prospects. Management has provided mid-single-digit EPS growth guidance, but the current pricing leaves little room for error if North American operations fail to stabilize or improve. Investors are closely monitoring whether the company can reverse its domestic decline to justify the expensive multiple. The market is balancing the appeal of a safe dividend yield against the risk that organic growth improvements in North America may be insufficient to sustain current valuations.